MACROGENICS INC — Director's Dealing 2019

May 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2019-05-20

Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-20	Common Stock	M	3000	$0.94	Acquired	33806	Direct
2019-05-20	Common Stock	S	3000	$18.377	Disposed	30806	Direct
2019-05-22	Common Stock	M	1000	$0.94	Acquired	31806	Direct
2019-05-22	Common Stock	S	1000	$19.026	Disposed	30806	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-20	Employee stock option (right to buy)	$0.94	M	3000	Disposed	2022-03-13	Common Stock (3000.0)	Direct
2019-05-22	Stock Option (right to buy)	$0.94	M	1000	Disposed	2020-01-09	Common Stock (1000.0)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2019.

F2: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $18.25 to $18.50. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.

F3: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $19.00 to $19.026. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.